The Event

In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 40 speakers will present a full conference programme covering the topics outlined below. These topics have been compiled as a result of a comprehensive research process undertaken with an expert advisory board with members including Executive Directors and Professors from global pharmaceutical organisations and leading research institutions.

Day 1 Stream 1 – Antibody Discovery & Engineering

• Moving beyond mAbs: novel bispecific formats and ADCs
• Novel ADC payloads and conjugation techniques
• Antibody pharmacokinetics (PK) and Pharmacodynamics (PD)
• New antibody discovery platforms
• Single domain and recombinant antibody tools

Day 1 Stream 2 – Protein Expression & Characterisation

• Emerging technologies for protein expression: imaging tools, nanodiscs and NMR
• Membrane proteins as key drug targets: overcoming purification and expression hurdles
• The latest updates in protein science:
  • proteomics
  • folding
  • pathway engineering
  • protein modification
• Designing the right proteins: combatting cost of goods with early stage drug design

Day 2 Stream 1 – Therapeutic Applications of Antibodies

• Novel bispecific antibodies and their therapeutic potential
• Next-generation affinity reagents: recombinant and engineered antibodies, nucleic acid aptamers
• Immuno-oncology: the latest research in targeting solid tumours
• Alternative scaffolds and novel antibody formats

Day 2 Stream 2 – Protein Purification & Downstream Processing

• Reducing protein production timelines with cell line development and novel disposable technologies
• Obtaining reference standards for therapeutic proteins
• Protein stability in pharmaceutical manufacturing:
  • storage concerns
  • extending ‘shelf life’
• Automation and robotics to enhance processing